New Study Finds Wider Adoption of Biosimilars Could Save States and Taxpayers Billions

A new study conducted by the Pacific Research Institute (PRI) found that wider adoption of biosimilars in the U.S. would create significant savings to state Medicaid programs and consumers with commercial insurance.